Lysine HCI

Food supplement declared in France, declaration No 2018-9-168, decision dated 6 September 2018

Lysine HCI is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand: not provided
Food business operator placing the product on the market: FLOREM
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: 1 gélule par jour
Not recommended for (according to the manufacturer): Adolescents (moins de 18 ans), Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims): Os, Immunité

Declaration 290897, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union. The declaration predates this removal: if the product is still sold, its formula must have changed; check the label.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.

Declared composition

Other active ingredients

Name	Per day
Chlorhydrate de lysine	not declared

Additives

E171, E172, E124, E104, E131

Other ingredients

gélatine

List from the declaration, administrative decision dated 6 September 2018 (Compl'Alim, food supplement declarations (France)).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.